Midas Letter

Backstageplay Inc (CVE:BP) (FRA:DOZB) CEO Scott White visits the Midas Letter studio to talk to James West about the growing trend of gamification. White explains that Backstageplay’s platform is geared toward the music industry and helps artists attract more fans and concert-goers while providing fans with once-in-a-lifetime experiences. As a result, Backstageplay is creating a previously untapped revenue stream for artists but uses a plug-and-play content platform that minimizes risk. The platform recently rolled out with Daughtry and James Maslow, but White sees broad applicability across all fandoms, such as WWE, the NFL, and internet influencers.

James West:   Hey, welcome back to Midas Letter Live. My guest in this segment is Scott White; he’s the CEO of Backstageplay Inc., trading on the TSX Venture under the symbol BP. Scott, welcome.

Scott White:  Thank you.

Isodiol International Inc (CNSX:ISOL) (OTCMKTS:ISOLD) (FRA:LB6B) Director Aman Parmar joins James West to discuss the manufacturing and distribution of therapeutic CBD products. Parmar talks about the two main pillars of Isodiol’s business model: pharmaceutical development, through the recently acquired BSPG Laboratories, and the manufacturing and distribution of CBD products. The pair discuss Isodiol’s anti-inflammatory products and the health benefits of CBD. Currently, the distribution of CBD products varies by region and country; Parmar expects the Farm Bill’s expected approval to increase distribution in the United States.

James West:   Welcome back. My guest this segment is Aman Parmar; he is a director of Isodiol International Inc., trading on the CSE under the symbol ISOL. Aman, welcome to the show.

Aman Parmar:  Great to be here.

Aurora Cannabis Inc (TSE:ACB) (OTCMKTS:ACBFF) (FRA:21P) CCO Cam Battley and Editorial Director of Cannabis Business Times and Cannabis Dispensary magazines Noelle Skodzinski joins James West for the first episode of Cannabis Corner. Results are announced for Micron Waste Technologies (CNSX:MWM) (OTCMKTS:MICWF) (FRA:7FM2) waste digestor naming contest. De-prohibition in the United States, Aurora’s Australis Capital Inc deal, and cannabis waste processes are all discussed.

James West:  Hey! Welcome to Midas Letter Live. In this segment we’re doing something brand new. We’re having a talk show style discussion. My first guest ever in this format are Cam Battley, Chief Corporate Officer from Aurora Cannabis Inc and our special guest is Noelle Skodzinski and she is the corporate; sorry what was the title again?

Noelle Skodzinski:  Editorial director.

James West:  Editorial director of Cannabis Business Times and Cannabis Dispensary. Hold those up. These are the magazines that are taking the United States by storm and we’re going to see them here soon too aren’t we?

Cam Ba

Alcanna Inc (TSE:CLIQ) (OTCMKTS:LQSIF) CEO James Burns discusses the company’s massive North American profile – being the largest private retailer of liquor in Canada. Alcanna are 25% owned by Aurora Cannabis Inc (TSE:ACB) (OTCMKTS:ACBFF) (FRA:21P), with the option to increase to 40 percent ownership through the exercise of warrants. Alcanna provides Aurora with a proven retail strategy using their long history and established distribution channels in liquor and adult consumable products. Burns also discusses opening retail cannabis stores under the “Aurora” brand name across Canada and the future opportunity Ontario provides both companies.

James West:    Hey, welcome back to Midas Letter Live. My guest in this segment is James Burns. He is the CEO of Alcanna Inc., trading on the TSX under the symbol CILQ. James, welcome.

James Burns:   Thank you.

Hempco Food and Fiber Inc (CVE:HEMP) (OTCMKTS:HMPPF) (FRA:22Y) CEO Diane Jang discusses the company’s range of available hemp-based consumer products and the future applications of hemp CBD.  As of October 17, the Cannabis Act will allow companies to extract and commercialize non-narcotic CBD’s from hemp flowers, leaves and chaff, which were previously all discarded. Aurora Cannabis Inc (TSE:ACB) (OTCMKTS:ACBFF) (FRA:21P) have a 52.5 percent share majority ownership in the company and Hempco will act as their mainstream food play. Hempco plan to capture market share of the growing, Infinium Global Research predicted 2.2 US billion dollar, hemp-based food industry.

James West:     Welcome back to Midas Letter Live. It’s Friday. And my guest right now is Diane Jane. She’s the CEO of Hempco Food and Fibre Inc trading on the TSX-V under the symbol H E M P. Diane welcome to the show.

Diane Jane:     Thank you James.

Emerald Health Therapeutics (CVE:EMH) (OTCMKTS:EMHTF) (FRA:TBD) CEO Chris Wagner discusses their recent deal to be part of the British Columbia retail market. Wagner explains that Emerald Health, the province’s largest cannabis producer, was recently licensed to sell out of its one million square foot facility in Delta, British Columbia. The pair talk about Emerald Health’s deal to acquire Northern Vine Canada, a licensed dealer, which allows Emerald Health to develop new, innovative products as part of its development push. Emerald’s “objective is to have multi-billion-dollar products that are patented, that we will sell all over the world” in medical markets such as Australia and Germany.

James West:   Hey, welcome back to Midas Letter Live. My guest in this segment is Chris Wagner; he’s the CEO of Emerald Health Therapeutics, trading on the Venture under the symbol EMH. Chris, thanks for joining me today.

Chris Wagner: Thanks, James. Good to be here.

Tilray Inc (NASDAQ:TLRY) (FRA:2HQ) CEO Brendan Kennedy discusses Tilray’s path toward becoming the first cannabis company to IPO on the US Exchange. Kennedy outlines Tilray’s current global footprint, highlighting the company’s expected growth on the cultivation side from 8 to 90 metric tons by the end of the year. The key to Tilray’s international growth is its facility in Portugal, which allows for both indoor and outdoor growing, and tariff-free access to European Union markets. Kennedy explains that the rapid increase in countries legalizing medical cannabis combined with Canada’s leading role in shifting recreational cannabis laws will result in changes to US law in the next 3 to 4 years.

James West:  Hey! Welcome back to Midas Letter Live. My guest this segment is Brendan Kennedy, CEO of Tilray. In trading on NASDAQ under the symbol TLRY. Brandon thank you for joining me again.

Brendan Kennedy: Thank you for having me.

James West: So, amazing transformat

Heritage Cannabis Holdings Corp (CNSX:CANN) (OTCMKTS:UMBBF) (FRA:2UE) Chairman Clint Sharples discusses the completion of Heritage’s buildout and licensing in Falkland, British Columbia under subsidiary PhyeinMed. Sharples addresses the need for indoor scalability to meet the needs of the Canadian retail market in 2019. Furthermore, he explains Heritage’s potential acquisition of CannaCure, a Niagara-based company with a 122,000 square foot greenhouse facility. The pair discuss Heritage’s CapEx requirements to meet Phase 2 plans for PhyeinMed and CannaCure.

James West:   Hey, welcome back to Midas Letter Live! In this segment, my guest is Clint Sharples, and he’s the Chairman of Heritage Cannabis Holdings Corp., trading on the CSE under the symbol CANN. Welcome back, Clint.

Clint Sharples:    Thank you. Nice to be back here again.

Aurora Cannabis Inc (TSX:ACB) (OTCQB:ACBFF) (FRA:21P) CCO Cam Battley has nothing but praise for Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) CEO Bruce Linton and the recent combination (effectively) of Constellation Brands (NYSE:STZ)and Canopy. But he also suggests that, just as it always has been, Aurora will be close on Canopy’s heels with its own value catalysts.

Transcript:

James West:    Cam Battley. What are you doing here?

Cam Battley:   James West. Hi.

James West:    You know, it’s so funny that you’re here right now.

Cam Battley:   Tell me, why is it so funny?

James West:    I just bought $10,000 worth of your stock. Do you know why I just upped my position by another $10,000?

Cam Battley:   Please, tell me.

James West:    Because you reminded me that I’m actually going to get a share and a warrant of Australis if I’m a shareholder of record on the date of record that is not yet announced, but you’re comfortable in telling me that.

Cam Battley:   Subject to the ratio that we have yet to determine and will announce, but yes.

James West:    Anyways, there’s a gift there.

Cam Battley:   There is a gift. It really, truly is a gift; it’s a gift to our shareholders, and we’re giving them something of significant value that we hope to turn into an awful lot more value in a very short period of time.

James West:    Righ

Canopy Growth Corp (TSE:WEED) (NYSE:CGC) (FRA:11L1) was one of the first successful investments for Follow The Money Investor Group Co-Founders (FTMIG). Brandon Colwell and Karl Boyd join James West in the Midas Letter studio to discuss their site’s potential to host constructive market discussion. Colwell and Boyd stress the due diligence and research commitment of FTMIG members. The trio examine the current state of cannabis stocks and evaluate potential growth in mining.  They outline the impact of the futures trading market on stagnant copper prices. Colwell talks about the growing number of knowledgeable retail investors interested in cannabis and how a community like FTMIG helps this type of investor.

James West:   Hey, welcome back to Midas Letter Live. My guest in this segment is Brandon Colwell and Karl Boyd.

Karl Boyd:    It’s a hard one.

James West:   I know! The co-founders of Follow The Money Investor Group, which you can find online at ftmig.com, or Facebook/followthemoneyinvestorgroup, all written out just like that. Gentlemen, thanks for joining me.

Karl Boyd:    You did that without even looking, too. That was fantastic.

James West:   I finally memorized it, because I said it 50 times before we started. So, Follow The Money Investor Group: tell me, how did it get started? How many members do you have, what’s the whole story?

Brandon Colwell:   Well, it started right here, and co-founder.

Karl Boyd:    Yeah, absolutely. You know what, my partner and I, we were in another group just speculating in the cannabis stocks about two or three years ago, and we really, really enjoyed that group. But there was a lot of conversations that weren’t being – it wasn’t very constructive.

James West:   Pumperdoodles?

Karl Boyd:    Well, yeah a lot of them. A lot of pumperdoodle.

James West:   [laughter] I hate that!

Karl Boyd:    I think it’s worse, though, just – it’s okay for people to not agree, but it’s how you’re going to go about your conversation and, you know, being constructive, right? So instead of fighting and arguing with people, which we were doing, we wanted to just, you know? Let’s do our own thing. Started our own Facebook group, and we’ll let people talk, but we’ll just moderate it, you know, a little bit, and people are just going to be insulting others, we’re not going to have that, right? So that’s sort of how it started.

James West:   Oh, okay.

Brandon Colwell:   And it’s just grown ever since. I mean, I came in around November or so, and they – remember Karl telling me, who on earth is this guy who just keeps talking? And I was a huge cannabis – still am, a huge cannabis advocate, because I’ve been in cannabis since Bedrocan. So I had Canopy at $1.60, and I never looked back.

James